A patient-derived, autologous component-integrated biomimetic hydrogel system for lung cancer organoid culture and recapitulation of immunotherapy response

BACKGROUND: Matrigel-based culture of patient-derived lung cancer organoids (LCOs) is limited by undefined composition, batch-to-batch variability, and immunogenicity, which compromise experimental reproducibility and drug response readouts. METHODS: We developed an autologous component-integrated hydrogel by incorporating patient-derived decellularized lung fiber fragments (1.25 μm diameter; 52.5 μm length) and optimized autologous plasma (56 °C, 30 min; 8,000×g, 5 min; 5% v/v) into a porous gelatin methacryloyl (GelMA) network. Five formulations-GelMA, GelMA+ fiber, GelMA + plasma, MC-GelMA (fibers + plasma) and Matrigel-were compared to dissect component contributions. LCOs were established from 8 patients, and PBMC co-culture experiments were performed with 3 samples (1 PD-L1-positive, 2 PD-L1-negative). RESULTS: MC-GelMA exhibited uniform porosity and a Young's modulus of 15.67 ± 0.86 kPa, closely matching native lung tumor tissue. Compared with Matrigel, LCOs cultured in MC-GelMA exhibited in vivo-like morphology, enhanced viability and metabolic activity, and preservation of key histological and genomic features.The platform supported stable long-term culture through passage 9 with maintained drug sensitivity. Component analysis revealed that fibers mainly provided structural and mechanical cues, while plasma supplied biochemical signals; their combination synergistically enhanced organoid growth and immune cell infiltration. In co-culture, MC-GelMA recapitulated anti-PD-L1 responses: PD-L1-positive organoids showed increased LDH release, whereas PD-L1-negative organoids did not respond. CONCLUSION: In conclusion, this autologous component-integrated biomimetic hydrogel serves as a highly reproducible biofabrication platform for stable LCO culture and reliable recapitulation of patient-specific immunotherapy response patterns. Further validation in larger cohorts is warranted to establish its predictive potential for clinical immunotherapy outcomes.

Authors

Institutions

Publication Details

Journal
Biofabrication
Published
2026-11-12
DOI
https://doi.org/10.1088/1758-5090/aec19a
Primary Topic
Hydrogels: synthesis, properties, applications
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

A patient-derived, autologous component-integrated biomimetic hydrogel system for lung cancer organoid culture and recapitulation of immunotherapy response

云舞扬, Huifeng Liu, Li Xiao, Yuyu Li et al.
Biofabrication
Hydrogels: synthesis, properties, applications
article

A patient-derived, autologous component-integrated biomimetic hydrogel system for lung cancer organoid culture and recapitulation of immunotherapy response

云舞扬, Huifeng Liu, Li Xiao, Yuyu Li, Wen Chen, Jing Yuan
article en

Abstract

BACKGROUND: Matrigel-based culture of patient-derived lung cancer organoids (LCOs) is limited by undefined composition, batch-to-batch variability, and immunogenicity, which compromise experimental reproducibility and drug response readouts. METHODS: We developed an autologous component-integrated hydrogel by incorporating patient-derived decellularized lung fiber fragments (1.25 μm diameter; 52.5 μm length) and optimized autologous plasma (56 °C, 30 min; 8,000×g, 5 min; 5% v/v) into a porous gelatin methacryloyl (GelMA) network. Five formulations-GelMA, GelMA+ fiber, GelMA + plasma, MC-GelMA (fibers + plasma) and Matrigel-were compared to dissect component contributions. LCOs were established from 8 patients, and PBMC co-culture experiments were performed with 3 samples (1 PD-L1-positive, 2 PD-L1-negative). RESULTS: MC-GelMA exhibited uniform porosity and a Young's modulus of 15.67 ± 0.86 kPa, closely matching native lung tumor tissue. Compared with Matrigel, LCOs cultured in MC-GelMA exhibited in vivo-like morphology, enhanced viability and metabolic activity, and preservation of key histological and genomic features.The platform supported stable long-term culture through passage 9 with maintained drug sensitivity. Component analysis revealed that fibers mainly provided structural and mechanical cues, while plasma supplied biochemical signals; their combination synergistically enhanced organoid growth and immune cell infiltration. In co-culture, MC-GelMA recapitulated anti-PD-L1 responses: PD-L1-positive organoids showed increased LDH release, whereas PD-L1-negative organoids did not respond. CONCLUSION: In conclusion, this autologous component-integrated biomimetic hydrogel serves as a highly reproducible biofabrication platform for stable LCO culture and reliable recapitulation of patient-specific immunotherapy response patterns. Further validation in larger cohorts is warranted to establish its predictive potential for clinical immunotherapy outcomes.

Biofabrication
Chinese PLA General Hospital (CN), Kailuan General Hospital (CN)
National Natural Science Foundation of China
Good health and well-being
Hydrogels: synthesis, properties, applications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon